Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2641 AL 2655

Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease

Xu XH, Huang Y, Wang G, Chen SD.

Neurosci Bull. 2012 Oct;28(5):641-8. doi: 10.1007/s12264-012-1272-0. Epub 2012 Oct 3.

Common transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple Sclerosis

Borjabad A, Volsky DJ.

J Neuroimmune Pharmacol. 2012 Dec;7(4):914-26. doi: 10.1007/s11481-012-9409-5. Epub 2012 Oct 12.

Tissue-based Alzheimer gene expression markers-comparison of multiple machine learning approaches and investigation of redundancy in small biomarker sets

Scheubert L, Luštrek M, Schmidt R, Repsilber D, Fuellen G.

BMC Bioinformatics. 2012 Oct 15;13:266. doi: 10.1186/1471-2105-13-266.

Translational proteomics in Alzheimer's disease and related disorders

Ghidoni R, Paterlini A, Benussi L.

Clin Biochem. 2013 Apr;46(6):480-6. doi: 10.1016/j.clinbiochem.2012.10.012. Epub 2012 Oct 23.

Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals

Lazarczyk MJ, Hof PR, Bouras C, Giannakopoulos P.

BMC Med. 2012 Oct 25;10:127. doi: 10.1186/1741-7015-10-127.

Comparison of International Working Group criteria and National Institute on Aging-Alzheimer's Association criteria for Alzheimer's disease

Visser PJ, Vos S, van Rossum I, Scheltens P.

Alzheimers Dement. 2012 Nov;8(6):560-3. doi: 10.1016/j.jalz.2011.10.008.

Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia

Noel-Storr AH, Flicker L, Ritchie CW, Nguyen GH, Gupta T, Wood P, Walton J, Desai M, Solomon DF, Molena E, Worrall R, Hayen A, Choudhary P, Ladds E, Lanctôt KL, Verhey FR, McCleery JM, Mead GE, Clare L, Fioravanti M, Hyde C, Marcus S, McShane R.

Alzheimers Dement. 2013 May;9(3):e96-e105. doi: 10.1016/j.jalz.2012.01.014. Epub 2012 Oct 27.

New criteria for Alzheimer disease and mild cognitive impairment: implications for the practicing clinician

Budson AE, Solomon PR.

Neurologist. 2012 Nov;18(6):356-63. doi: 10.1097/NRL.0b013e31826a998d.

Clinical diagnosis in preclinical stage of Alzheimer's disease

Fuentes P.

Arch Med Res. 2012 Nov;43(8):667-70. doi: 10.1016/j.arcmed.2012.10.014. Epub 2012 Nov 3.

Emerging noninvasive biomarkers for early detection of Alzheimer's disease

Guzmán-Martínez L, Farías GA, Maccioni RB.

Arch Med Res. 2012 Nov;43(8):663-6. doi: 10.1016/j.arcmed.2012.10.013. Epub 2012 Nov 7.

Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementia

Román G, Pascual B.

Arch Med Res. 2012 Nov;43(8):671-6. doi: 10.1016/j.arcmed.2012.10.018. Epub 2012 Nov 8.

Biomarker evidence for uncoupling of amyloid build-up and toxicity in Alzheimer's disease

Zetterberg H, Blennow K.

Alzheimers Dement. 2013 Jul;9(4):459-62. doi: 10.1016/j.jalz.2012.07.002. Epub 2012 Nov 14.

Finding a pathological diagnosis for Alzheimer's disease: are inflammatory molecules the answer?

Bhamra MS, Ashton NJ.

Electrophoresis. 2012 Dec;33(24):3598-607. doi: 10.1002/elps.201200161. Epub 2012 Nov 26.

Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer's disease?

Brown BM, Peiffer JJ, Martins RN.

Mol Psychiatry. 2013 Aug;18(8):864-74. doi: 10.1038/mp.2012.162. Epub 2012 Nov 20.

Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?

Mullane K, Williams M.

Biochem Pharmacol. 2013 Feb 1;85(3):289-305. doi: 10.1016/j.bcp.2012.11.014. Epub 2012 Nov 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias